Search

Search Results for "neovascular AMD"

Bausch + Lomb VISUDYNE^® (verteporfin for injection)

Exploring Treatment Strategies for Wet AMD and DME

Surgical options for treating AMD: Clinical Implications and Impact

Real-world impact of patients lost to follow-up: factors that drive nonadherence and strategies for encouraging better follow-up from patients

Fluid in Neovascular Age-Related Macular Degeneration – Evolution of Understanding

Thumbnail for ovoor

Anti-VEGF Maintenance Therapy for Neovascular AMD

Carl Regillo, MD, Timothy G. Murray MD, MBA, FACS

Thumbnail for bbjel

FOUNDERS LECTURE: Gene Therapy for Neovascular AMD 2019: Pitfalls and Promise

Allen C. Ho, MD, Timothy G. Murray, MD, MBA

Thumbnail for ogeva

OCTA for a Case of Neovascular AMD

Pravin Dugel, MD

Thumbnail for owill

OSPREY and OWL: A Pair of Phase 2 Clinical Trials Evaluating RTH258 for Neovascular AMD

Rishi P. Singh, MD

Thumbnail for asile

Results of ESBA 1008, a Single-Chain Antibody Fragment, for the Treatment of Neovascular AMD

Pravin Dugel, MD

Neovascular AMD (PCV Variant) Patient Switched to Two Different Next-generation Therapies thumbnail

Neovascular AMD (PCV Variant) Patient Switched to Two Different Next-generation Therapies

David Miller, MD; Ehsan Rahimy, MD; and Esther Kim, MD

Fluid on Focus: Neovascular AMD Management Redefined by ZEISS Retina Workflow thumbnail

Fluid on Focus: Neovascular AMD Management Redefined by ZEISS Retina Workflow

Ricardo Leitão Guerra, MD, MSc, FICO

St<strike>ep</strike>upid Edits in a Neovascular AMD Patient thumbnail

Stepupid Edits in a Neovascular AMD Patient

David Miller, MD; Ehsan Rahimy, MD; and Esther Kim, MD

Switching from Bevacizumab to Aflibercept 8 mg in a Neovascular AMD Patient After Handoff from a Colleague thumbnail

Switching from Bevacizumab to Aflibercept 8 mg in a Neovascular AMD Patient After Handoff from a Colleague

David Miller, MD; Ehsan Rahimy, MD; and Esther Kim, MD

Using multi-modality in ZEISS Retina Workplace: A case of Neovascular AMD thumbnail

Using multi-modality in ZEISS Retina Workplace: A case of Neovascular AMD

Eric W. Schneider, MD

Thumbnail for cnlac

Efficacy and Duration in AMD Therapeutic Trials

Conversion to Neovascular AMD in a Geographic Atrophy Patient With a 2-Year Treatment History thumbnail

Conversion to Neovascular AMD in a Geographic Atrophy Patient With a 2-Year Treatment History

David Miller, MD; Ehsan Rahimy, MD; and Esther Kim, MD

Thumbnail for lvbot

Optimizing Long-Term Visual Outcomes in Wet AMD

Carl D. Regillo, MD, Timothy G. Murray, MD, MBA

Switching From Bevacizumab to Aflibercept 8 mg in a Patient With Neovascular AMD thumbnail

Switching From Bevacizumab to Aflibercept 8 mg in a Patient With Neovascular AMD

David Miller, MD; Ehsan Rahimy, MD; and Esther Kim, MD

Switching From Aflibercept 2 mg to Faricimab in a Patient With Newly Diagnosed Neovascular AMD and Worsening Pigment Epithelium Detachment thumbnail

Switching From Aflibercept 2 mg to Faricimab in a Patient With Newly Diagnosed Neovascular AMD and Worsening Pigment Epithelium Detachment

David Miller, MD; Ehsan Rahimy, MD; and Esther Kim, MD

NIDEK's Mirante Retro Mode thumbnail

Retro Mode on the NIDEK Mirante

Thomas Desmettre, MD, PhD

View More